Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Piera Gargiulo
Preoperative Chemotherapy and Radiotherapy Concomitant to Cetuximab in Resectable Stage IIIB NSCLC: A Multicentre Phase 2 Trial (SAKK 16/08)
British Journal of Cancer
Cancer Research
Oncology
Related publications
P2.17-27 IMpower030: Phase III Study Evaluating Neoadjuvant Treatment of Resectable Stage II-IIIB NSCLC With Atezolizumab + Chemotherapy
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Pre-Operative Chemotherapy in Early Stage Resectable Non-Small-Cell Lung Cancer: A Randomized Feasibility Study Justifying a Multicentre Phase III Trial
British Journal of Cancer
Cancer Research
Oncology
126TiP SAKK 16/14: Anti-Pd-L1 Antibody Durvalumab (MEDI4736) in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-Small Cell Lung Cancer (NSCLC): A Multicenter Single-Arm Phase II Trial
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P2.16-03 CheckMate 816: A Phase 3 Trial of Neoadjuvant Nivolumab Plus Ipilimumab or Chemotherapy vs Chemotherapy in Early-Stage NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P3.17-12 Phase II Trial of Atezolizumab Before and After Chemoradiation for Unresectable Stage III NSCLC (AFT-16): Trial in Progress
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
A Phase II Study of Cetuximab, Capecitabine and Radiotherapy in Neoadjuvant Treatment of Patients With Locally Advanced Resectable Rectal Cancer
European Journal of Surgical Oncology
Medicine
Oncology
Surgery
Mitomycin C and Vinorelbine for Second-Line Chemotherapy in NSCLC – A Phase II Trial
British Journal of Cancer
Cancer Research
Oncology
Oral Vinorelbine and Cisplatin With Concomitant Radiotherapy in Stage III Non-Small Cell Lung Cancer (NSCLC): A Feasibility Study
Oncology Research and Treatment
Cancer Research
Oncology
Hematology
P2.01-48 Predictive Factors in NSCLC Patients With Stage IIIB/IV Treated With First Line Platinum-Doublet Chemotherapy
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary